Admoxy is a penicillin-based antibiotic that works by combating bacteria in the body. It is effective for treating various bacterial infections, including sinusitis, pneumonia, ear infections, bronchitis, urinary tract infections, and skin infections. However, it is not effective against viral infections such as the common cold.
Potassium clavulanate, a derivative of clavulanic acid, is commonly used in combination with penicillin antibiotics like amoxicillin to treat bacterial infections. As a β-lactamase inhibitor, clavulanate potassium prevents the breakdown of amoxicillin by bacterial enzymes.
Amoxicillin is vulnerable to degradation by β-lactamase-producing bacteria, which are resistant to many β-lactam antibiotics like penicillin. To counter this, potassium clavulanate is added to protect the amoxicillin from being inactivated. This combination helps to enhance the antibiotic's effectiveness.
Amoxicillin trihydrate is most stable in an acidic environment, and its stability decreases with higher pH levels. Potassium clavulanate, being pH neutral, does not affect the pH balance of the medication.
Admoxy contains two different medicines, Amoxycillin and Potassium Calavulunate, that work together to kill the bacteria that cause infections. Amoxycillin works by stopping the growth of bacteria Potassium Clavulanate offers improved stability and solubility, making it more suitable.
